NCT00079092 2021-09-09
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
Wake Forest University Health Sciences
Phase 2 Completed
Wake Forest University Health Sciences
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer